Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks IPOs and placings
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
London pre-open: Small gains expected early on
(Sharecast News) - UK stocks are expected to start the second quarter in positive territory, with the FTSE 100 called to open around the 8,000 mark on Tuesday. The FTSE 100, which rose 0.3% in a shortened trading week last week, gained 3% over the first three months of the year to settle at 7,952.62 on Thursday. According to Bloomberg, futures were showing a rise of around 45 to 50 points early on.
"Following a robust first quarter for risk assets, market bulls were poised to maintain their dominance entering the second quarter buoyed by positive data from China and optimism surrounding the Federal Reserve's preferred price gauge, released late last week," said Stephen Innes, managing partner a SPI Asset Management.
"This gauge was perceived, rightly or wrongly, as sufficient to allay concerns about inflation despite recent Consumer Price Index overshoots."
The PCE index showed that annual inflation in the US rose to 2.5% in February from 2.4% the month before - the first acceleration since September. However, the core annual rate fell to 2.8% from 2.9%.
Tuesday looks like another busy session in terms of economic data, with UK lending and house price figures due out, along with Germany inflation and US job openings, along with a number of hotly anticipated speeches from members of the Federal Reserve.
In corporate news, America's drug regulator gave the green light to AstraZeneca for the add-on use of Voydeva in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH). PNH is a condition under which some patients' immune systems destroy a larger proportion of red blood cells than they should, whilst EVH was the condition in which red blood cells outside of blood vessels were destroyed. Voydeva could now be used as an add-on therapy to ravulizumab or eculizumab to treat EVH in adults with PNH.
Bank of Georgia updated the market on the acquisition of Ameriabank, having now received regulatory clearance from the National Bank of Georgia. The FTSE 250 company received shareholder approval for the purchase on 14 March. With subsequent unconditional approvals from Armenian regulatory bodies, including the Competition Protection Commission and the Central Bank of Armenia, Bank of Georgia said it could now move to finalise the acquisition agreement. (edited)
RHI Magnesita said it was buying Resco Group, a US-based producer of alumina monolithics and wide range of basic and non-basic refractories, for up to $430m. Resco makes products for use in the petrochemical, cement, aluminium, and steel making industries operating seven plants and two raw material sites in the US and two plants in the UK and Canada.
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity and Inclusion | Doing Business with Fidelity | Fidelity gender pay report | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Security | Statutory and Regulatory disclosures | Whistleblowing policy
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.